Global Liquid Biopsy Market to 2032
Overview
The Global Liquid Biopsy Market is expected to reach a 8,434.69 USD Billion by 2032 and is projected to grow at a CAGR of 16.40% from 2025 to 2032.
Revenue, 2024 (USD Billion)
2,515.60
Forecast, 2032 (USD Billion)
8,434.69
CAGR, 2024 - 2032
16.40%
Report Coverage
Global
Global Liquid Biopsy Market 2018-2032 USD Billion
Global Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2,515.60 USD Billion
- Projected Market Size (2032): 8,434.69 USD Billion
- CAGR (2025-2032): 16.40%
Key Findings of Global Liquid Biopsy Market
- The Global Liquid Biopsy Market was valued at 8,434.69 USD Billion in 2024.
- The Global Liquid Biopsy Market is likely to grow at a CAGR of 16.40% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Multi-Gene-Parallel Analysis in Technology Segment accounted for the largest share of the market with a revenue of 1,973.21 USD Billion
- The fastest growing segment Routine Screening in Clinical Application Segment grew Fastest with a CAGR of 19.32% during the forecast period from 2024 to 2032.
Global Liquid Biopsy Market Scope
Global Liquid Biopsy Market Segmentation & Scope
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Technology
- Multi-Gene-Parallel Analysis
- Single Gene Analysis
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Product
- Services & Software
- Instruments
- Consumables & Accessories
Biomaker
- Circulating Tumor Cells (CTCS)
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Global Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2,515.60 USD Billion |
| Market Value in 2032 | 8,434.69 USD Billion |
| CAGR (2025-2032) | 16.40% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Clinical Application,Application,Technology,End User,Distribution Channel,Analytical,Product,Biomaker,Sample |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 2,515.60 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,187.87 USD Billion in 2024.
Segments and Scope
-
Global Liquid Biopsy Market to 2032, By Clinical Application
- Routine Screening is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,074.37 USD Billion in the year 2024.
- Routine Screening is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 19.32 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Application
- Cancer Applications is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,963.25 USD Billion in the year 2024.
- Cancer Applications is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 16.83 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Technology
- Multi-Gene-Parallel Analysis is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,973.21 USD Billion in the year 2024.
- Multi-Gene-Parallel Analysis is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 16.89 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By End User
- Hospitals is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,454.36 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 17.14 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,690.17 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 16.95 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Analytical
- Molecular is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,451.04 USD Billion in the year 2024.
- Proteomic is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 17.02 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Product
- Consumables & Accessories is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,355.87 USD Billion in the year 2024.
- Consumables & Accessories is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 17.11 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Biomaker
- Circulating Tumor Cells (CTCS) is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,004.91 USD Billion in the year 2024.
- Circulating Tumor Cells (CTCS) is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 18.71 % in forecast period 2025-2032.
-
Global Liquid Biopsy Market to 2032, By Sample
- Blood Sample-Based is the largest segment in Global Liquid Biopsy Market to 2032 with a revenue of 1,404.42 USD Billion in the year 2024.
- Blood Sample-Based is the Fastest growing segment in Global Liquid Biopsy Market to 2032 with a Growth rate of 17.47 % in forecast period 2025-2032.
Global Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Guardant Health | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
Global Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Liquid Biopsy Market is segmented based on Segmentation Clinical Application,Application,Technology,End User,Distribution Channel,Analytical,Product,Biomaker,Sample.
Global Liquid Biopsy Market was valued at USD 2,515.60(Revenue in USD Billion) in 2021.
Global Liquid Biopsy Market is projected to grow at a CAGR of 16.40% during the forecast period of 2024 to 2032.
The Multi-Gene-Parallel Analysis segment is expected to dominate the Global Liquid Biopsy Market, holding a largest market share of 1,973.21 USD Billion in 2024
Global Liquid Biopsy Market Scope
Global Liquid Biopsy Market Segmentation & Scope
Clinical Application
- Others
- Patient Work-Up
- Recurrence Monitoring
- Treatment Monitoring
- Therapy Selection
- Routine Screening
Application
- Non-Cancer Applications
- Cancer Applications
Technology
- Multi-Gene-Parallel Analysis
- Single Gene Analysis
End User
- Others
- Research Centres and Academic Institutes
- Diagnostics Centers
- Reference Laboratories
- Hospitals
Distribution Channel
- Others
- Third Party Distributor
- Direct Tender
Analytical
- Histology/Imaging
- Proteomic
- Molecular
Product
- Services & Software
- Instruments
- Consumables & Accessories
Biomaker
- Circulating Tumor Cells (CTCS)
- Others
- Extracellular Vesicles
- Exosomes
- Cell-Free RNA
- Circulating Cell-Free DNA (CFDNA)
Sample
- Others
- Saliva & Other Tissue Fluids Sample-Based
- Urine Sample-Based
- Blood Sample-Based
Frequently Asked Questions
The Global Liquid Biopsy Market is segmented based on Segmentation Clinical Application,Application,Technology,End User,Distribution Channel,Analytical,Product,Biomaker,Sample.
Global Liquid Biopsy Market was valued at USD 2,515.60(Revenue in USD Billion) in 2021.
Global Liquid Biopsy Market is projected to grow at a CAGR of 16.40% during the forecast period of 2024 to 2032.
The estimated market value of the Global Liquid Biopsy Market for final year is USD 8,434.69 (USD Billion).
Global Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Global Liquid Biopsy Market is segmented based on Segmentation Clinical Application,Application,Technology,End User,Distribution Channel,Analytical,Product,Biomaker,Sample.
Global Liquid Biopsy Market was valued at USD 2,515.60(Revenue in USD Billion) in 2021.
Global Liquid Biopsy Market is projected to grow at a CAGR of 16.40% during the forecast period of 2024 to 2032.
The estimated market value of the Global Liquid Biopsy Market for final year is USD 8,434.69 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.